Cargando…
Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study
Studies have suggested that women with elevated BMI or 25-OH vitamin D levels may derive less benefit from AIs versus tamoxifen. We prospectively investigated whether high BMI or 25-OH vitamin D levels were associated with higher estrogen levels in post-menopausal women receiving standard adjuvant l...
Autores principales: | Elliott, Mitchell J., Ennis, Marguerite, Pritchard, Kathleen I., Townsley, Carol, Warr, Dave, Elser, Christine, Amir, Eitan, Bedard, Philippe L., Rao, Lakshmi, Stambolic, Vuk, Sridhar, Srikala, Goodwin, Pamela J., Cescon, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293309/ https://www.ncbi.nlm.nih.gov/pubmed/32566743 http://dx.doi.org/10.1038/s41523-020-0166-y |
Ejemplares similares
-
Association of Metabolic, Inflammatory, and Tumor Markers With Circulating Tumor Cells in Metastatic Breast Cancer
por: Lohmann, Ana Elisa, et al.
Publicado: (2018) -
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
por: Kim, Jisun, et al.
Publicado: (2014) -
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer
por: Pezo, Rossanna C., et al.
Publicado: (2017) -
Understanding the benefit of metformin use in cancer treatment
por: Dowling, Ryan JO, et al.
Publicado: (2011) -
Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006)
por: Ahn, Sung Gwe, et al.
Publicado: (2021)